OPRX and DOCS are betting big on AI-driven healthcare engagement as cautious pharma spending pressures near-term growth.
OPRX's shares slid 30% in a month as MFN pricing and cautious pharma spending hit revenue, even as DAAP growth and EBITDA surged.
OptimizeRx expands DSP integration to unlock scalable EHR ad campaigns and boost inventory use despite lowering 2026 revenue guidance.
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
| CE Curtis Ellergodt Rothschild Investment LLC | 5 | $61 | $34.2 | -$26.8 | -43.93% |
| LJB Laura J. Bornheimer GWN SECURITIES Inc. | 54,850 | $478,158.76 | $372,431.5 | -$105,727.26 | -22.11% |
Joseph Castro Nuveen LLC | 38,998 | $474,722.59 | $262,179.65 | -$212,542.94 | -44.77% |
Bobby Adusumilli SJS Investment Consulting Inc. | 44 | $276.32 | $296.56 | $20.24 | 7.32% |
Ana-Maria Ignat Covestor Ltd | 1,914 | $25,839 | $12,823.8 | -$13,015.2 | -50.37% |
| Software Industry | Information Technology Sector | Stephen L. Silvestro CEO | NASDAQ (CM) Exchange | 68401U204 CUSIP |
| US Country | 133 Employees | - Last Dividend | 14 May 2018 Last Split | 22 Oct 1996 IPO Date |
OptimizeRx Corporation is a pioneering digital health technology company, established in 2006 and headquartered in Waltham, Massachusetts. It specializes in facilitating communication between life sciences organizations, healthcare providers, and patients at various crucial points throughout the patient care journey. By leveraging its innovative technology, OptimizeRx Corporation aims to improve patient outcomes and support healthcare providers by delivering timely and relevant treatment information. The company's focus on care-focused engagement stands out in the healthcare technology sector, making it a key player in driving advancements in digital health care solutions.
This platform represents the core of OptimizeRx’s offerings. It employs artificial intelligence to generate dynamic audiences and enable the execution of both traditional and dynamic marketing campaigns. Traditional marketing campaigns can run on OptimizeRx’s proprietary digital point-of-care network, which includes healthcare providers and patients. The more innovative aspect, however, lies in its dynamic marketing campaigns. These campaigns adjust and optimize audiences in real time based on clinical care events, ensuring that healthcare professionals and patients receive the most relevant and timely treatment information. This real-time optimization enhances the effectiveness of communication between pharmaceutical companies, healthcare providers, and patients, ultimately aiming to improve patient care outcomes.